NIH-funded research U01 cooperative agreement

Point-of-care esophageal cancer detection in low- and middle-income countries

Official title: Point-of-Care Diagnosis of Esophageal Cancer in LMICs

Funded at Johns Hopkins University · NIH-11535323 · Data updated 2026-11-12

A researcher-led effort to use a swallowable sponge and a portable chip to detect DNA methylation markers of esophageal cancer right where patients live, helping people in LMICs get quick results.

More Esophageal Cancer research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startJuly 1, 2023
Project endJune 30, 2028
Funding year2026
Award (this year)$62,247
NIH project number3U01CA279866-04S1
Project IDNIH-11535323 on NIH RePORTER

Who could benefit from this research

Could help

Adults at risk for esophageal squamous cell carcinoma in LMICs who could benefit from a non-invasive screening test.

Less likely to help

People without risk factors for ESCC or in settings where the test cannot be practically implemented may not benefit.

What this research studies

This project aims to simplify early ESCC detection in low-resource settings by using a swallowable sponge to collect esophageal cells and a small magnetic chip to process and test DNA methylation at the point of care. The approach is designed to be used without advanced endoscopy and without extensive medical training, so testing can occur in remote clinics. The study focuses on developing and validating a fast, safe, and locally operable diagnostic workflow to identify high-risk patients for timely referral and treatment.

Why it matters

Potential benefit: If successful, patients in LMICs could receive faster and more accessible ESCC screening and referral, potentially improving survival.

How similar studies have gone: Past work supports the feasibility of non-invasive methylation-based markers; this study advances a portable, field-ready workflow in LMICs.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Meltzer, Stephen J — Johns Hopkins University
  • Study coordinator: Meltzer, Stephen J

Related research

Other NIH-funded projects on the same topics.

  • AI-guided microendoscopy to detect esophageal cancer早期

    A doctor-research team is testing an AI-assisted microendoscopy tool to screen people at risk for esophageal cancer, aiming to find cancer early with higher accuracy and fewer unnecessary biopsies.

    NIH research Baylor College of Medicine · Houston, United States · NIH-11535395

  • AI-assisted Microendoscopy to Detect Esophageal Cancer Earlier

    A technology-based approach uses AI and a tiny endoscopy device to screen for early esophageal cancer, focusing on high-risk regions around the world.</n>

    NIH research Baylor College of Medicine · Houston, United States · NIH-11535393

  • AI-assisted Microendoscopy for early esophageal cancer detection

    A Baylor College of Medicine team is testing a mobile, AI-driven microscopic imaging tool to help screen for early esophageal cancer in regions with limited screening capacity.

    NIH research Baylor College of Medicine · Houston, United States · NIH-11413535

  • OmicXScreen: AI-powered blood test to detect liver and esophageal cancers early

    A new blood test using AI and DNA methylation patterns aims to detect hepatocellular carcinoma and esophageal cancer early, helping people who are at high risk.

    NIH research Omicxhealth, INC. · San Ramon, United States · NIH-11404601

  • AI-assisted microendoscopy to find esophageal cancer early

    This project uses a small, high-resolution endoscope plus AI to help doctors spot early esophageal cancer in people at risk, especially where screening is limited.

    NIH research Baylor College of Medicine · Houston, United States · NIH-11397210

  • AI-assisted microendoscope to find esophageal cancer early

    This project uses a small, high-resolution endoscope plus artificial intelligence to help doctors spot early esophageal squamous cell cancer in people at risk, especially where screening is scarce.

    NIH research Baylor College of Medicine · Houston, United States · NIH-11397207

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.